The trial’s primary efficacy goal is to measure the rate of growth of atrophic lesions in the retina. Credit: SaiArLawKa2 / Shutterstock.com. Belite Bio has concluded the final participant visit in ...

Amidst significant shifts in the pharmaceutical industry, the number of clinical trials has surged over the first half of ...

Karyopharm Therapeutics has reached a significant milestone by completing patient enrolment for its Phase III SENTRY trial.

PhaseV has entered into a strategic partnership with Bioforum to enhance the efficiency of clinical trials using advanced ...

As the IASLC 2025 World Conference on Lung Cancer approaches, CTA looks at some of the most promising NSCLC assets in Phase ...

Transformative new shifts have taken place in the last month in the metabolic dysfunction-associated steatohepatitis (MASH) ...

In August, Regeneron announced positive results from Phase III clinical trial NIMBLE evaluating the efficacy and safety of ...

Takeda’s readout comes from two pivotal Phase III trials of its OX2R, with Alkermes’ data coming from a Phase II trial in NT1 ...

Revolution will now explore daraxonrasib’s potential as a monotherapy and in combination with chemotherapy in late-stage PDAC trials.

Alnylam has disclosed new analysis findings from the HELIOS-B Phase III clinical trial of RNA interference (RNAi) therapeutic ...

RealTime eClinical Solutions has rolled out the TrialAlign platform that aims to refine the performance analytics for ...

In the real-world trial, Novo Nordisk's Wegovy showed a significant reduction in CV events compared to Eli Lilly’s Zepbound.